Journal of Autoimmunity

Article	Citations
Pulmonary and serum cytokine profiles of patients with anti-ARS and anti-MDA5 antibodies	368
Janus kinase inhibition prevents autoimmune diabetes in LEW.1WR1 rats	224
Optimizing the tapering scheme of corticosteroid treatment for acute onset of autoimmune hepatitis	185
HNF4α, SP1 and c-myc are master regulators of CNS autoimmunity	130
Immunosuppression induces regression of fibrosis in primary biliary cholangitis with moderate-to-severe interface hepatitis	122
Control of naive and effector CD4 T cell receptor repertoires by rheumatoid-arthritis-risk HLA alleles	119
Infectious and non-infectious precipitants of sarcoidosis	96
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors	93
GILZ regulates type I interferon release and sequesters STAT1	91
Disease status in human and experimental arthritis, and response to TNF blockade, is associated with MHC class II invariant chain (CD74) isoform expression	85
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination	84
Nuclear translocation of RIG-I promotes cellular apoptosis	83
Autoimmune diseases and the risk of bladder cancer: A Mendelian randomization analysis	75
Post COVID-19 hospitalizations in patients with chronic inflammatory diseases – A nationwide cohort study	74
ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis	71
miR-147-3p in pathogenic CD4 T cells controls chemokine receptor expression for the development of experimental autoimmune diseases	70
Editorial Board	69
Editorial Board	68
Editorial Board	67
Editorial Board	67
Editorial Board	65
Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis	58
Editorial Board	57
A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile	57
Antigen-driven autoantibody production in lungs of interstitial lung disease with autoimmune disease	55

Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination	55
Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases	54
Impact of coding risk variant IFNGR2 on the B cell-intrinsic IFN-γ signaling pathway in multiple sclerosis	53
Suppression of YTHDF2 attenuates autoimmune hepatitis by expansion of myeloid-derived suppressor cells	51
Reconstituted CD74+ NK cells trigger chronic graft versus host disease after allogeneic bone marrow transplantation	49
VNN2-expressing circulating monocytes exhibit unique functional characteristics and are decreased in patients with primary Sjögren's syndrome	49
Editorial Board	48
Editorial Board	47
Identification of new telomere- and telomerase-associated autoantigens in systemic sclerosis	47
Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak	46
Advances in SLE classification criteria	46
Adding salt to foods and risk of psoriasis: A prospective cohort study	46
UBE2L3 regulates TLR7-induced B cell autoreactivity in Systemic Lupus Erythematosus	45
Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis	45
Adenosine-to-inosine RNA editing contributes to type I interferon responses in systemic sclerosis	44
Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors	41
Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system mice	39
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?	39
Fecal microbiota transplantation in the treatment of systemic lupus erythematosus: What we learnt from the explorative clinical trial	39
Autoreactive memory Th17 cells are principally derived from T-bet+RORγt+ Th17/1 effectors	38
Short term outcomes of COVID-19 in lupus: Propensity score matched analysis from a nationwide multi-centric research network	37
Intrarenal synthesis of complement C3 localized to distinct vascular compartments in ANCA-associated renal vasculitis	36
Application of laboratory models for sarcoidosis research	35
Acute-type acquired hemophilia A after COVID-19 mRNA vaccine administration: A new disease entity?	34
Genetic and pharmacological targeting of GSDMD ameliorates systemic inflammation in macrophage activation syndrome	34
CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis	34
COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study	33
Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis	32
Single cell transcriptomic analysis of Graves’ disease thyroid glands reveals the broad immunoregulatory potential of thyroid follicular and stromal cells and implies a major re-interpretation of the	32
CADHERIN-11 regulation of myeloid phagocytes and autoimmune inflammation in murine lupus	30
Natural IgG protects against early dissemination of vesicular stomatitis virus	30
Phenotypes in antiphospholipid syndrome: A hierarchical cluster analysis based on two independent databases	30
EZH2 promotes B-cell autoimmunity in primary Sjogren's syndrome via METTL3-mediated m6A modification	29
Pin1 maintains the effector program of pathogenic Th17 cells in autoimmune neuroinflammation	29
Balancing efficacy and safety of complement inhibitors	28
Th1-like Treg in vitiligo: An incompetent regulator in immune tolerance	28
High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis	28
Sex-specific analysis in Behçet's disease reveals higher genetic risk in male patients	27
CD72-semaphorin3A axis: A new regulatory pathway in systemic lupus erythematosus	27
The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial	26
A novel humanized cutaneous lupus erythematosus mouse model mediated by IL-21-induced age-associated B cells	26
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients	26
Mitochondrial N-formyl methionine peptides associate with disease activity as well as contribute to neutrophil activation in patients with rheumatoid arthritis	25
Proteomic analyses of plasma-derived exosomes in immunoglobulin (Ig) G4-related disease and their potential roles in B cell differentiation and tissue damage	25
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination	25
Identification of a novel PDC-E2 epitope in primary biliary cholangitis: Application for engineered Treg therapy	25
Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression	24
Telomeres: New players in immune-mediated inflammatory diseases?	24
Associations between CD70 methylation of T cell DNA and age in adults with systemic lupus erythematosus and population controls: The Michigan Lupus Epidemiology & Surveillance (MILES) Program	24
Neural autoantibodies in delirium	24

SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis	24
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients	23
Pulmonary sarcoidosis: A comprehensive review: Past to present	23
Dendritic cells in systemic lupus erythematosus: From pathogenesis to therapeutic applications	22
Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis	22
Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials	21
Enhanced type I interferon signature induces neutrophil extracellular traps enriched in mitochondrial DNA in adult-onset Still's disease	21
CD8 follicular T cells localize throughout the follicle during germinal center reactions and maintain cytolytic and helper properties	21
Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination	20
Differences in innate immune cell populations distinguish autoimmune from herpesvirus-associated encephalitis	20
Elevated unphosphorylated STAT1 and IRF9 in T and B cells of primary sjögren's syndrome: Novel biomarkers for disease activity and subsets	20
Compositional and functional aberrance of the gut microbiota in treatment naïve patients with primary Sjögren's syndrome [J. Autoimmun., 134, January 2023, 102958]	19
Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: An analysis of European data	19
Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis	19
Corrigendum to “Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis” [J. Autoimmun. 119C (2021) 102629]	19
Interferon (IFN)-stimulated gene 15: A novel biomarker for lymphoma development in Sjögren's syndrome	19
Signal responses to neutral TSH receptor antibody – A cycle of damage in the pathophysiology of Graves’ disease	18
T helper cell immunity in pregnancy and influence on autoimmune disease progression	18
Transcriptomic profiling of iris tissue highlights LCK signaling and T cell-mediated immunity in Behcet's uveitis	18
Poorer survival for patients with inflammatory arthritis treated with immune checkpoint inhibitors for melanoma	18
Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features	17
COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases	17
In cis “benign” SOCS1 variants linked to enhanced interferon signaling and autoimmunity	17
Long-term (16–26 years) follow-up outcome of steroid therapy in refractory autoimmune sensorineural hearing loss	17
Editorial Board	17
Editorial Board	17
Cerebrospinal fluid proteomics indicates immune dysregulation and neuronal dysfunction in antibody associated autoimmune encephalitis	17
Cognitive dysfunction in SLE: An understudied clinical manifestation	17
Editorial Board	17
Editorial Board	17
Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus	17
PD-1 antibody interactions with Fc gamma receptors enable PD-1 agonism to inhibit T cell activation – therapeutic implications for autoimmunity	16
Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis	16
Evidence for charge-based mimicry in anti dsDNA antibody generation	16
Inflammation dynamically regulates steroid hormone metabolism and action within macrophages in rheumatoid arthritis	16
Identifying the most influential gene expression profile in distinguishing ANCA-associated vasculitis from healthy controls	16
Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease	16
Impaired dynamic X-chromosome inactivation maintenance in T cells is a feature of spontaneous murine SLE that is exacerbated in female-biased models	15
Antigen-specific T cells and autoimmunity	15
Antimyeloperoxidase antibodies modulate inflammatory responses and activate profibrotic pathways in human monocytes	15
Molecular signature of neutrophil extracellular trap mediating disease module in idiopathic inflammatory myopathy	15
Global and regional epidemiology of psoriatic arthritis in patients with psoriasis: A comprehensive systematic analysis and modelling study	15
Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases	15
Autoreactivity to self-antigens LL37 and ADAMTSL5 influences the clinical response to risankizumab in psoriatic patients	15
Amelioration of immunoglobulin A vasculitis by suppression of the pathological expansion of T follicular helper 17 cells	14
Regulatory T cells effectively downregulate the autoimmune anti-MPO response and ameliorate anti-MPO induced glomerulonephritis in mice	14
Hoigné’s syndrome, an uncommon mimicker of anaphylaxis: Systematic literature review	14
Breach of tolerance versus burden of bile acids: Resolving the conundrum in the immunopathogenesis and natural history of primary biliary cholangitis	14
Developmental drugs for sarcoidosis	14
Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING)	14
Targeting the endo-lysosomal autophagy pathway to treat inflammatory bowel diseases	13
Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis	13
Corrigendum to “Cell surface-expressed Ro52/IgG/HLA-DR complex is targeted by autoantibodies in patients with inflammatory myopathies” [J. Autoimmun. 126 (2022) 102774]	13
Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application	13
Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination	13
Erratum to “Safety and efficacy of fecal microbiota transplantation for treatment of systemic lupus erythematosus: An EXPLORER trial” [J. Autoimmun. 130, June 2022, 102844]	13
Chronic inflammation in high-fat diet-fed mice: Unveiling the early pathogenic connection between liver and adipose tissue	13
Tfh cell-derived small extracellular vesicles exacerbate the severity of collagen-induced arthritis by enhancing B-cell responses	12
Wiskott–Aldrich syndrome protein maintains regulatory T cell tolerance by modulating their surface IL-2 receptor levels	12
ETS-1 facilitates Th1 cell-mediated mucosal inflammation in inflammatory bowel diseases through upregulating CIRBP	12
Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk	12
Lupus nephritis: new progress in diagnosis and treatment	12
Salivary gland epithelial cell in Sjögren's syndrome: Metabolic shift and altered mitochondrial morphology toward an innate immune cell function	12
Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis	12
Novel autoantibodies to the β-cell surface epitopes of ZnT8 in patients progressing to type-1 diabetes	12
Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p	12
Tolerogenic IL-10-engineered dendritic cell-based therapy to restore antigen-specific tolerance in T cell mediated diseases	11
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations	11
Ectopic CD4+ T cells in choroid plexus mediate neuropsychiatric lupus symptoms in mice via interferon-γ induced microglia activation	11
Neutrophil-derived extracellular vesicles induce endothelial inflammation and damage through the transfer of miRNAs	11
Circulating T cells in sarcoidosis have an aberrantly activated phenotype that correlates with disease outcome	11
Regulatory B cells in autoimmune diseases: Insights and therapeutic potential	11
Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy	11
hsa-miR-424–5p and hsa-miR-513c-3p dysregulation mediated by IFN-γ is associated with salivary gland dysfunction in Sjögren's syndrome patients	11
SB431542 alleviates lupus nephritis by regulating B cells and inhibiting the TLR9/TGFβ1/PDGFB signaling	11
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease	11
Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis	11
Ferritin – from iron, through inflammation and autoimmunity, to COVID-19	11
Regulatory T cells in autoimmune hepatitis: an updated overview	10
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: A descriptive cohort study among 1.1 million vaccinated people in Hong Kong	10

Alternative splicing and intron retention: Their profiles and roles in cutaneous fibrosis of systemic sclerosis	10
Genetic predisposition to sarcoidosis	10
HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes	10
Old known and possible new biomarkers of ANCA-associated vasculitis	10
Effect of opioid receptor antagonist on mitigating tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-induced apoptolysis in pemphigus pathogenesis	10
Quality of life in sarcoidosis	10
Cognition following chimeric antigen receptor T-cell therapy: A systematic review	10
The 2022 outbreak and the pathobiology of the monkeypox virus	10
Cellular pathways and molecular events that shape autoantibody production in COVID-19	10
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow	10
Genetic association and differential expression of HLA Complex Group lncRNAs in pemphigus	9
The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential	9
Fecal microbiota transplantation for the management of autoimmune diseases: Potential mechanisms and challenges	9
Thrombocytopenia after COVID-19 vaccination	9
miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis	9
Immune recognition of lysyl-tRNA synthetase and isoleucyl-tRNA synthetase by anti-OJ antibody-positive sera	9
Expanding the landscape of systemic sclerosis-related autoantibodies through RNA immunoprecipitation coupled with massive parallel sequencing	9
Outcome and prognosis of isolated carotid vasculitis	9
The landscape of T and B lymphocytes interaction and synergistic effects of Th1 and Th2 type response in the involved tissue of IgG4-RD revealed by single cell transcriptome analysis	9
Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis	9
Monoclonal antibodies from B cells of patients with anti-MDA5 antibody-positive dermatomyositis directly stimulate interferon gamma production	9
Gluten-free diet reduces autoimmune diabetes mellitus in mice across multiple generations in a microbiota-independent manner	9
Kidney manifestations of sarcoidosis	9
Outcome of COVID-19 in hospitalized patients with chronic inflammatory diseases. A population based national register study in Denmark	8
Histological pattern of non-infectious thoracic aortitis impacts mortality	8
Antigenic mimicry – The key to autoimmunity in immune privileged organs	8
Editorial Board	8
Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases	8
Autoimmune hepatitis following COVID-19 vaccination	8
Editorial Board	8
On the peptide binding affinity changes in population-specific HLA repertoires to the SARS-CoV-2 variants Delta and Omicron	8
Cellular communication network factor 3 contributes to the pathological process of rheumatoid arthritis through promoting cell senescence and osteoclastogenesis in the joint	8
Editorial Board	8
Editorial Board	8
Kinase activity profiling reveals contribution of G-protein signaling modulator 2 deficiency to impaired regulatory T cell migration in rheumatoid arthritis	8
Whole blood transcriptome identifies interferon-regulated genes as key drivers in thrombotic primary antiphospholipid syndrome	8
Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP	8
Editorial Board	8
IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis	8
UHRF1P contributes to IL-17A-mediated systemic lupus erythematosus via UHRF1-MAP4K3 axis	7
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus	7
Sunscreen use associated with elevated prevalence of anti-nuclear antibodies in U.S. adults	7
Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes	7
CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody	7
Inflammatory disease status and response to TNF blockade are associated with mechanisms of endotoxin tolerance	7
Quantitative and structural changes of blood platelet cytoskeleton proteins in multiple sclerosis (MS)	7
Characteristics of immune response profile in patients with immediate allergic and autoimmune urticarial reactions induced by SARS-CoV-2 vaccines	7
Metabolic enzyme Suclg2 maintains tolerogenicity of regulatory dendritic cells diffDCs by suppressing Lactb succinylation	7
Extracellular microRNAs induce dendritic cell-dependent joint inflammation and potentiate osteoclast differentiation via TLR7/8 engagement	7
Microchimeric cells promote production of rheumatoid arthritis-specific autoantibodies	7
Epidemiologic and genetic associations between primary biliary cholangitis and extrahepatic rheumatic diseases	7
Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFNγ in myositis	7
Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis	7
Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data	7
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19	7
Repeated immunization with ATRA-containing liposomal adjuvant transdifferentiates Th17 cells to a Tr1-like phenotype	7
Gene-expression profiling of laser-dissected islets and studies in deficient mice reveal chemokines as differential driving force of type 1 diabetes	7
Impaired IL-6-induced JAK-STAT signaling in CD4+ T cells associates with longer treatment duration in giant cell arteritis	7
Autophagy pathways in autoimmune diseases	7
Thyroid cells from normal and autoimmune thyroid glands suppress T lymphocytes proliferation upon contact revealing a new regulatory inhibitory type of interaction independent of PD1/PDL1	7
Novel biomarker discovery through comprehensive proteomic analysis of lupus mouse serum	6
Mucosal-associated invariant T cells in Giant Cell Arteritis	6
Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies	6
Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4+ T cells in giant cell arteritis	6
Circulating immune profile in granulomatosis with polyangiitis reveals distinct patterns related to disease activity	6
Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications	6
Editorial Board	6
Sonic hedgehog promotes synovial inflammation and articular damage through p38 mitogen-activated protein kinase signaling in experimental arthritis	6
Conformational state of C-reactive protein is critical for reducing immune complex-triggered type I interferon response: Implications for pathogenic mechanisms in autoimmune diseases imprinted by type	6
Comparative effectiveness of preventive treatment with dimethyl fumarate-loaded solid lipid nanoparticles and oral dimethyl fumarate in a mouse model of multiple sclerosis	6
Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice	6
Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus	6
Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus	6
Glycobiology of psoriasis: A review	6
Isolation and characterisation of PR3-specific B cells and their immunoglobulin sequences	6
Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients	6
Autoantibodies targeting malondialdehyde-modifications in rheumatoid arthritis regulate osteoclasts via inducing glycolysis and lipid biosynthesis	6
A case of Graves' disease and type 1 diabetes mellitus following SARS-CoV-2 vaccination	6
Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease	6
AIM2 deficiency in CD4+ T cells promotes psoriasis-like inflammation by regulating Th17-Treg axis via AIM2-IKZF2 pathway	6
Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection	6
A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score	5
The role of faecal microbiota transplantation in chronic noncommunicable disorders	5
Glucocorticoid use as a cause of non-cellular immune response to SARS-Cov2 Spike in patients with immune system diseases	5
Pathogenesis, multi-omics research, and clinical treatment of psoriasis	5
Fecal microbiota transplantation: Emerging applications in autoimmune diseases	5
Pre-existing conditions associated with post-acute sequelae of COVID-19	5
Clinical disease activity and flare in SLE: Current concepts and novel biomarkers	5
Caspase-10 affects the pathogenesis of primary biliary cholangitis by regulating inflammatory cell death	5
Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments	5
Transcriptome landscape of double negative T cells by single-cell RNA sequencing	5
Progress and unmet needs in understanding fundamental mechanisms of autoimmunity	5
Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus	5
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort	5
Regulatory B cells in patients suffering from inborn errors of immunity with severe immune dysregulation	5